Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.840
-0.315 (-14.62%)
At close: Aug 13, 2025, 4:00 PM
1.940
+0.100 (5.43%)
Pre-market: Aug 14, 2025, 8:57 AM EDT
Autolus Therapeutics Stock Forecast
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for Autolus Therapeutics stock ranges from a low of $5.00 to a high of $13. The average analyst price target of $9.12 forecasts a 395.65% increase in the stock price over the next year.
Price Target: $9.12 (+395.65%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Autolus Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $6 → $5 | Buy | Maintains | $6 → $5 | +171.74% | Aug 13, 2025 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +443.48% | Jul 21, 2025 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +443.48% | Jun 12, 2025 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +443.48% | Apr 10, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +443.48% | Apr 1, 2025 |
Financial Forecast
Revenue This Year
57.92M
from 10.12M
Increased by 472.28%
Revenue Next Year
124.47M
from 57.92M
Increased by 114.92%
EPS This Year
-0.93
from -0.86
EPS Next Year
-0.81
from -0.93
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 81.9M | 168.7M | 473.6M | ||
| Avg | 57.9M | 124.5M | 265.0M | ||
| Low | 39.0M | 89.7M | 110.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 708.9% | 191.2% | 280.5% | ||
| Avg | 472.3% | 114.9% | 112.9% | ||
| Low | 285.0% | 54.8% | -11.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.55 | -0.37 | -0.17 | ||
| Avg | -0.93 | -0.81 | -0.57 | ||
| Low | -1.23 | -1.16 | -1.01 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.